Atlas Trials

Myotonic Dystrophy Type 1

20 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch Myotonic Dystrophy Type 1

RecordFirmDate
Assessing Clinical Endpoints and Biomarkers in Myotonic Dystrophy Type-1 and Type 2 (ASCEND-DM) (NCT03867435)National Institute of Neurological Disorders and Stroke (NINDS)2020-02-24
PhenoDM1 (Myotonic Dystrophy Type 1 Natural History Study) (NCT02831504)Newcastle-upon-Tyne Hospitals NHS Trust2015-08-01
A Safety andTolerability Study of Multiple Doses of ISIS-DMPKRx in Adults With Myotonic Dystrophy Type 1 (NCT02312011)Ionis Pharmaceuticals, Inc.2014-12-01
Observational Prolonged Trial in Myotonic Dystrophy Type 1 (NCT02118779)Radboud University Medical Center2014-04-02
Children's Health Research Institute(CHRI), Stanford Lucile Packard Children Hospital (LPCH) Protocol on Myotonic Dystrophy (NCT02269865)Stanford University2013-12-01
Multicenter Observational Study of Myotonic Dystrophy Type 1 (NCT02308657)University of Rochester2013-11-01
Safety and Efficacy Study of Recombinant Human Insulin-Like Growth Factor-I/Recombinant Human Insulin-Like Growth Factor Binding Protein-3 (rhIGF-I/rhIGFBP-3) In Myotonic Dystrophy Type 1 (NCT00577577)Insmed Incorporated2007-12-01

Track Myotonic Dystrophy Type 1 automatically

Every clearance here is in the API, with alerts when new ones post.